Fresenius, DE000FRE5EN2

Fresenius stock after-hours at EUR 43.88: minus 1.66 percent versus prior close

Published on 10/01/2026 at 19:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fresenius stock was at EUR 43.88 after-hours at 7:33 p.m. CEST on October 1, 2026, down 1.66 percent versus the prior close at Lang & Schwarz. Fresenius also outlined a hospital-services restructuring.

Fresenius SE – Fotorealistisch: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht
Fresenius SE & Co. KGaA (ISIN DE0005785604) ist ein internationaler Gesundheitskonzern mit Sitz in Bad Homburg. Das Unternehmen betreibt Krankenhäuser und entwickelt Arzneimittel und Infusionslösungen. Dieses Bild zeigt: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht, Illustration mit AI erstellt.

Fresenius stock was at EUR 43.88 after-hours at 7:33 p.m. CEST on October 1, 2026, down EUR 0.74, or 1.66 percent, versus the prior close of EUR 44.62 at Lang & Schwarz.

Trading after the Xetra close

The price indication was below the previous Lang & Schwarz close of EUR 44.62. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Fresenius stock.

Hospital-services reorganization planned

In a September 16, 2026 update, Fresenius said it will integrate the hospital services provided internally for Helios into Helios Kliniken GmbH from January 1, 2027. The company said around 1,700 of more than 4,000 employees of Fresenius Health Services and its service companies will move to Helios. Fresenius Health Services will focus on external customers, which already account for around two-thirds of its revenue, according to Fresenius Investor Relations.

Disclaimer...

en | DE000FRE5EN2 | FRESENIUS | boerse | 70212218 | bgmi